News

April 2022

• 4/6 - Study explores perceptions of and preferences for complementary and integrative medicine options for chronic headache

• 4/6 - As number of ICU survivors increase, study validates first tool to utilize caregiver input to assess post-ICU syndrome symptoms

• 4/4 - Despite syphilis increase in U.S., 1 in 5 pregnant women not tested

March 2022

• 3/31 - Technology has the potential to change the patient-provider relationship  

• 3/30 - National study finds that any booster strategy is more effective than single J&J vaccine to prevent moderate to severe COVID-19

• 3/29 - Regenstrief researcher, IU Medical School faculty national urology award recipient

• 3/25 - Innovative AI technology aids personalized care for diabetes patients needing complex drug treatment

• 3/24 - Experts call to create standardized criteria for mask mandates based on objective data; 5 criteria proposed

• 3/23 - Current Regenstrief center director named interim president and CEO

• 3/22 - Editorial co-authored by Regenstrief researcher-clinician highlights indispensable role of home health aides in the era of COVID-19 and beyond

• 3/14 - Making high-performing healthcare more accessible in the US: The ongoing debate on universal healthcare coverage

• 3/9 - More severe stroke patients should receive palliative care consultations

• 3/7 - Addressing healthcare needs of transgender adults: Qualitative study finds 3 main barriers to receiving primary care in a supportive environment

• 3/4 - The increasing importance of HIE alerts for care coordination and evidence that they work

• 3/3 - New LOINC® release features streamlined file structure and two new translations

• 3/1 - Vaccines are effective in preventing COVID-19-related emergency department and urgent care visits for both children and adolescents

February 2022

• 2/17 - Researchers draw analogies between art and science in new study

• 2/15 - Regenstrief Research Scientist Thomas Imperiale named IU distinguished professor

• 2/11 - First study to show waning effectiveness of 3rd dose of mRNA vaccines

• 2/10 - Challenges of deprescribing and minimizing use of anticholinergic medications

• 2/9 - Regenstrief scientist wins emerging leadership award

• 2/2 - Regenstrief scientist appointed 1st chief of new IU School of Medicine palliative medicine section

• 2/1 - Prioritized supportive care needs of patients and caregivers during active cancer treatment 

January 2022

• 1/26 - AI models can predict individual risk of hospitalization for COVID using HIE data

• 1/24 - Local mask policy matters when it comes to public health

• 1/21 - Three doses of mRNA COVID-19 vaccines are very effective in protecting against emergency department visits and hospitalizations associated with Omicron and Delta variations of the virus

• 1/13 - Intervention leads to increase in primary care screenings for older adults

• 1/11 - Pediatric asthma study one of first to demonstrate successful use of health information exchange data to signal childhood disease trends

• 1/6 - Study finds long-stay nursing home residents under age 60 transferred to hospitals twice as often as residents older than 80

• 1/4 - Promise of mobile technology provided to hospitalists not impacting patient care

December 2021

• 12/16 - Regenstrief to co-lead new VA fellowship program with focus on learning health systems

• 12/13 - More than just resiliency training: Organizations need to address causes of burnout 

• 12/10 - Building a better dashboard for enhanced understanding of health

• 12/7 - Emergency departments are vital to care coordination efforts to reduce readmissions

• 12/6 - Regenstrief names new director of clinical informatics fellowship program

• 12/2 - Data can help address health disparities

November 2021

• 11/16 - Study tackles reducing bladder cancer recurrence

• 11/15 - No FIT: Colon cancer screening FIT doesn’t belong in emergency and inpatient settings

• 11/12 - Regenstrief and IU Fairbanks researcher honored with statewide healthcare award

• 11/10 - Regenstrief showcases research, expertise at 2021 AMIA symposium

• 11/9 - LOINC® contract with CMS extended for five years

• 11/4 - Regenstrief Institute’s contract with national COVID-19 collaborative extended

• 11/2 - Vaccines less effective at protecting against severe COVID-19 in immunocompromised adults

October 2021

• 10/29 - COVID vaccines 5 times more effective at protecting against COVID-related hospitalization than prior infection alone

• 10/27 - Vulnerable populations not receiving cancer survivorship care plans

• 10/20 - Regenstrief researcher wins human factors and ergonomics innovators award

• 10/19 - Newer depression screeners successfully measure symptoms and follow progress of treatment

• 10/12 - Addressing the challenges faced by physicians underrepresented in medicine

• 10/11 - Tachinardi named interim president and CEO of Regenstrief Institute

• 10/8 - Regenstrief researcher elected as fellow of National Academy of Kinesiology